{"id":56109,"date":"2023-04-22T04:04:52","date_gmt":"2023-04-22T02:04:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/"},"modified":"2023-04-22T04:04:52","modified_gmt":"2023-04-22T02:04:52","slug":"government-of-ontario-invests-in-virica-biotech","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/","title":{"rendered":"Government of Ontario Invests in Virica Biotech"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\nTo Expand Domestic Vaccine Manufacturing Capacity<\/p>\n<p>OTTAWA, Canada&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/AAV?src=hash\" target=\"_blank\" rel=\"noopener\">#AAV<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.viricabiotech.com&amp;esheet=53385128&amp;newsitemid=20230421005091&amp;lan=en-US&amp;anchor=Virica+Biotech+Inc.+%28%26%238220%3BVirica%26%238221%3B%29%2C&amp;index=1&amp;md5=5ac786cc91c95bba3090c00e92060bd4\" rel=\"nofollow noopener\" shape=\"rect\">Virica Biotech Inc. (\u201cVirica\u201d),<\/a> a leading supplier and developer of novel viral enhancers, announced today it is expanding its bioprocessing facilities and increasing its capacity to scale up the manufacturing of viral medicines and vaccines. The Government of Ontario is supporting the expansion at sites in Ottawa with a $790,000 grant from the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ontario.ca%2Fpage%2Fontario-together-fund-program-guidelines&amp;esheet=53385128&amp;newsitemid=20230421005091&amp;lan=en-US&amp;anchor=Ontario+Together+Fund&amp;index=2&amp;md5=e0b5c492ad33e2a815beb3965c07e4fc\" rel=\"nofollow noopener\" shape=\"rect\">Ontario Together Fund<\/a> (\u201cOTF\u201d).<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/5\/ViricaLogo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg\"><\/a><\/p>\n<p>\nThe expansion project aims to (i) grow Virica\u2019s bioprocessing capacity to keep pace with client demand for scaling up viral medicines, (ii) advance new vaccine process development lines, and (iii) support Ontario\u2019s preparedness for future public health emergencies with an off-the-shelf viral enhancement kit that will amplify vaccine production multifold.<\/p>\n<p>\n\u201cThrough the Ontario Together Fund, our government is investing in innovative homegrown businesses to build our medtech ecosystem,\u201d said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. \u201cWe are proud to partner with Virica as they expand Canada\u2019s vaccine manufacturing capacity.\u201d<\/p>\n<p>\n\u201cOur government is proud to support the expansion of Virica\u2019s lab facilities and strengthen their bioprocessing capacity. We\u2019re ensuring Ontario-made solutions are available to our vaccine manufacturing partners,\u201d said Goldie Ghamari, MPP for Carleton.<\/p>\n<p>\n\u201cOntario Together funding is a boost to Virica\u2019s continued growth,\u201d said Dr. Jean Simon Diallo, CEO of Virica Biotech. \u201cOur product line of viral enhancers enables us to seize the massive opportunity to reduce bioprocessing bottlenecks for viral medicine manufacturers, and increase manufacturing yields and quality of essential viral-based therapies and vaccines.\u201d<\/p>\n<p>\nVirica Biotech successfully launched its first Process Innovation Facility in May 2021, in partnership with the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ottawa-innovation.ca%2F&amp;esheet=53385128&amp;newsitemid=20230421005091&amp;lan=en-US&amp;anchor=Ottawa+Health+Innovation+Hub&amp;index=3&amp;md5=2574926c8a2ee85b8b8be9d65185fa4a\" rel=\"nofollow noopener\" shape=\"rect\">Ottawa Health Innovation Hub<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.annualreport.ottawaheart.ca%2F&amp;esheet=53385128&amp;newsitemid=20230421005091&amp;lan=en-US&amp;anchor=University+of+Ottawa+Heart+Institute&amp;index=4&amp;md5=a358d29b5e0ed47752e864a4d9b2c967\" rel=\"nofollow noopener\" shape=\"rect\">University of Ottawa Heart Institute<\/a><i>. <\/i>The global upstream bioprocessing market, which includes viral medicine and vaccines, will exceed C$17B in 2027 and is expected to grow at an annual rate of 12.8% thereafter.<\/p>\n<p>\n<b>About Virica Biotech<br \/>\n<br \/><\/b>Virica develops viral enhancers that optimize the manufacturing of viral medicines, allowing developers to economically deploy their products at scale. Virica\u2019s Viral Sensitizer (VSE\u2122) platform reduces production inefficiencies caused by innate anti-viral defenses in manufacturing cells. Customized VSE formulations substantially increase manufacturing yields and reduce the cost of goods for a range of products, including vaccines, gene therapies, and cell therapies. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.viricabiotech.com&amp;esheet=53385128&amp;newsitemid=20230421005091&amp;lan=en-US&amp;anchor=viricabiotech.com&amp;index=5&amp;md5=bd9bb19c257715f6caa891f972202dcb\" rel=\"nofollow noopener\" shape=\"rect\">viricabiotech.com<\/a><\/p>\n<p>\nPhotos available upon request.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<strong>Media:<\/strong><br \/>Jennifer Cameron, Communications, Virica Biotech<br \/>\n<br \/>T: 1 902 209 4704 \/ E: <a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#67;o&#x6d;&#109;u&#x6e;&#105;c&#x61;&#116;i&#x6f;&#110;s&#x40;&#118;i&#x72;&#105;c&#x61;&#98;i&#x6f;&#116;e&#x63;&#104;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x43;&#x6f;&#x6d;&#109;&#117;ni&#x63;&#x61;&#x74;&#x69;&#111;&#110;s&#64;&#x76;&#x69;&#x72;&#105;&#99;&#97;bi&#x6f;&#x74;&#x65;&#99;&#104;&#46;c&#x6f;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>To Expand Domestic Vaccine Manufacturing Capacity OTTAWA, Canada&#8211;(BUSINESS WIRE)&#8211;#AAV&#8212;Virica Biotech Inc. (\u201cVirica\u201d), a leading supplier and developer of novel viral enhancers, announced today it is expanding its bioprocessing facilities and increasing its capacity to scale up the manufacturing of viral medicines and vaccines. The Government of Ontario is supporting the expansion at sites in Ottawa &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56109","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Government of Ontario Invests in Virica Biotech - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Government of Ontario Invests in Virica Biotech - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"To Expand Domestic Vaccine Manufacturing Capacity OTTAWA, Canada&#8211;(BUSINESS WIRE)&#8211;#AAV&#8212;Virica Biotech Inc. (\u201cVirica\u201d), a leading supplier and developer of novel viral enhancers, announced today it is expanding its bioprocessing facilities and increasing its capacity to scale up the manufacturing of viral medicines and vaccines. The Government of Ontario is supporting the expansion at sites in Ottawa ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-22T02:04:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Government of Ontario Invests in Virica Biotech\",\"datePublished\":\"2023-04-22T02:04:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230421005091\\\/en\\\/1439953\\\/21\\\/ViricaLogo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/\",\"name\":\"Government of Ontario Invests in Virica Biotech - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230421005091\\\/en\\\/1439953\\\/21\\\/ViricaLogo.jpg\",\"datePublished\":\"2023-04-22T02:04:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230421005091\\\/en\\\/1439953\\\/21\\\/ViricaLogo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230421005091\\\/en\\\/1439953\\\/21\\\/ViricaLogo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/government-of-ontario-invests-in-virica-biotech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Government of Ontario Invests in Virica Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Government of Ontario Invests in Virica Biotech - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/","og_locale":"en_US","og_type":"article","og_title":"Government of Ontario Invests in Virica Biotech - Pharma Trend","og_description":"To Expand Domestic Vaccine Manufacturing Capacity OTTAWA, Canada&#8211;(BUSINESS WIRE)&#8211;#AAV&#8212;Virica Biotech Inc. (\u201cVirica\u201d), a leading supplier and developer of novel viral enhancers, announced today it is expanding its bioprocessing facilities and increasing its capacity to scale up the manufacturing of viral medicines and vaccines. The Government of Ontario is supporting the expansion at sites in Ottawa ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-22T02:04:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Government of Ontario Invests in Virica Biotech","datePublished":"2023-04-22T02:04:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/"},"wordCount":394,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/","url":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/","name":"Government of Ontario Invests in Virica Biotech - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg","datePublished":"2023-04-22T02:04:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230421005091\/en\/1439953\/21\/ViricaLogo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/government-of-ontario-invests-in-virica-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Government of Ontario Invests in Virica Biotech"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56109"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56109\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}